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Abstract
Background: Interleukin-33 (IL-33) belongs to the IL-1 cytokine family and resides in the nuclei of various cell types.
In the neural retina, IL-33 is predominately expressed in Müller cells although its role in health and disease is ill-
defined. Müller cell gliosis is a critical response during the acute phase of retinal detachment (RD), and in this study,
we investigated if IL-33 was modulatory in the inflammatory and neurodegenerative pathology which is
characteristic of this important clinical condition.
Methods: RD was induced by subretinal injection of sodium hyaluronate into C57BL/6 J (WT) and IL-33−/− mice and
confirmed by fundus imaging and optical coherence tomography (OCT). The expression of inflammatory cytokines,
complement components and growth factors was examined by RT-PCR. Retinal neurodegeneration, Müller cell
activation and immune cell infiltration were assessed using immunohistochemistry. The expression of inflammatory
cytokines in primary Müller cells and bone marrow-derived macrophages (BM-DMs) was assessed by RT-PCR and
Cytometric Bead Array.
Results: RD persisted for at least 28 days after the injection of sodium hyaluronate, accompanied by significant
cone photoreceptor degeneration. The mRNA levels of CCL2, C1ra, C1s, IL-18, IL-1β, TNFα, IL-33 and glial fibrillary
acidic protein (GFAP) were significantly increased at day 1 post-RD, reduced gradually and, with the exception of
GFAP and C1ra, returned to the basal levels by day 28 in WT mice. In IL-33−/− mice, RD induced an exacerbated
inflammatory response with significantly higher levels of CCL2, IL-1β and GFAP when compared to WT. Sustained
GFAP activation and immune cell infiltration was detected at day 28 post-RD in IL-33−/− mice. Electroretinography
revealed a lower A-wave amplitude at day 28 post-RD in IL-33−/− mice compared to that in WT RD mice. IL-33−/−
mice subjected to RD also had significantly more severe cone photoreceptor degeneration compared to WT
counterparts. Surprisingly, Müller cells from IL-33−/− mice expressed significantly lower levels of CCL2 and IL-6
compared with those from WT mice, particularly under hypoxic conditions, whereas IL-33−/− bone marrow-derived
macrophages expressed higher levels of inducible nitric oxide synthase, TNFα, IL-1β and CCL2 after LPS + IFNγ
stimulation compared to WT macrophages.
Conclusion: IL-33 deficiency enhanced retinal degeneration and gliosis following RD which was related to
sustained subretinal inflammation from infiltrating macrophages. IL-33 may provide a previously unrecognised
protective response by negatively regulating macrophage activation following retinal detachment.
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Background
Retinal detachment (RD) is a sight-threatening condition
that can occur spontaneously or as a complication of
trauma, inflammation and in diseases such as age-
related macular degeneration and proliferative diabetic
retinopathy. Retinal Müller cells are central to the
pathophysiology of RD, being involved in gliosis, initi-
ation of inflammatory cascades and/or proliferative re-
sponses [1]. Reactive microglia and macrophages are
also prevalent in the RD retina where they play a key
role in neurodegeneration and photoreceptor depletion
[2]. Microglia may also have a protective role as deple-
tion of microglia resulted in increased photoreceptor
death in experimental RD [3]. Dysregulated Müller cell
activation can lead to or exacerbate this pathology, with
evidence suggesting that there is direct communication
with professional immune cells through the CD40-ATP-
P2X7 pathway [4]. Recent studies have shown that inter-
leukin (IL)-33, a nuclei-binding cytokine, is expressed
predominately in Müller cells in the neuroretina [5] al-
though its role in retinal glial pathophysiology remains
ill-defined.
IL-33 belongs to the IL-1 cytokine family which in-
cludes IL-1β and IL-18. Unlike other members of this
family, IL-33 is constitutively expressed at high levels in
the nuclei of many cell types including endothelial, glial
and some immune cells [6]. Under healthy conditions,
IL-33 participates in maintaining physiological function
of IL-33-expressing cells by regulating gene expression
as a nuclear protein [6, 7]. Nuclear IL-33 negatively af-
fects gene transcription in an intracrine fashion by se-
questration of NF-kB leading to the repression of gene
expression to dampen pro-inflammatory pathways [6, 7].
Nuclear IL-33 can also function as an “alarmin” once it
is released from damaged or dead cells [6, 7]. When oc-
curring extracellularly, IL-33 binds to a heterodimeric
receptor complex consisting of ST2 and the IL-1R
accessory protein (IL-1RAP) which induces signalling
cascades through the Toll/interleukin-1 receptor (TIR)
domain [6, 8]. Activation of the IL-33 receptor induces a
Th2-type immunity [9], which can be pro-inflammatory
(such as IL-1β, TNFα, IL-4, IL-6, and CCL2) [10] or
anti-inflammatory (e.g., IL-10) [11].
Previously, we have shown that IL-33 can suppress ret-
inal inflammation in a mouse model of autoimmune
uveoretinitis [12], while Theodoropoulou et al. reported
that this cytokine can protect the retina from pathogenic
angiogenesis through reducing the activation and migra-
tion of choroidal endothelia and fibroblasts [13]. In con-
trast to studies showing IL-33-mediated protection
against retinal pathology, Xi and colleagues have re-
ported that IL-33-expressing-Müller cells can promote
inflammation and contribute to the pathogenesis of age-
related macular degeneration [14]. Therefore, the precise
role of IL-33 in inflammation-mediated, acute-phase ret-
inal neurodegeneration warrants further investigation.
In the current study, we assessed the role of IL-33 in
inflammatory and neurodegenerative pathology arising
from RD. We have found that the expression of IL-33 is
increased in the detached retina, which is accompanied
by reactive glial activation. Genetic deletion of IL-33 re-
sulted in sustained retinal inflammation, Müller glial ac-
tivation and a more severe photoreceptor degeneration
in RD.
Methods
Animals and animal procedures
IL-33−/− mice [15] were obtained from RIKEN Center
for Life Science Technologies (Japan, http://www.clst.
riken.jp/arg/mutant%20mice%20list.html, Accession No
CDB0631K). This colony was on the C57BL/6 N back-
ground and carried the rd8 mutation. The colony was
cross-bred with C57BL/6 J (WT) mice to eliminate the
rd8 mutation in the animal facility in Trinity College
Dublin before transferred to Queen’s University Belfast.
C57BL/6 J (WT) and IL-33−/− mice were maintained in
the Biological Service Unit (BSU) at Queen’s University
Belfast and had free access to food and water. In vivo
procedures were approved by the UK Home Office Ani-
mals (Scientific Procedures) Act 1986 and local Animal
Welfare and Ethical Review Board (AWERB) and were
in compliance of the Association for Research in Vision
and Ophthalmology (ARVO) Statement for the use of
Animals in Ophthalmology and Vision Research.
RD was induced by subretinal injection of sodium hya-
luronate (Alcon, TX, USA) into 3–4-month-old mice
[16, 17]. Briefly, the pupils were dilated with 1% atropine
sulphate and 2.5% phenylephrine hydrochloride (Chau-
vin, Essex, UK) and the animals were anesthetised with
isoflurane (Merial Animal Health Ltd., Essex, UK). Vis-
cotears Liquid Gel (Novartis Pharmaceuticals Ltd., Sur-
rey, UK) was then applied on the eyes to keep them
moist, and the vitreous cavity was visualised under a sur-
gical microscope with the aid of applying a cover slip on
top of the cornea. Then a 33 G needle connected to a
microsyringe/dispenser (Hamilton Bonaduz AG, Bonaduz,
Switzerland) was inserted into the subretinal space and
2 μl of sodium hyaluronate was gently injected to detach
the neurosensory retina from the underlying retinal pig-
ment epithelia (RPE). The eyes were collected at different
time points as indicated in the “Results” section.
Ganzfeld electroretinography (ERG) was performed on
mice at day 28 post-RD using a Diagnosys Espion system
(Diagnosys Technologies, MA, USA) in compliance with
the manufacturer’s guidelines. Mice were dark-adapted
overnight, and the procedures were conducted under
dim-red light (< 1 lx). Mice were anaesthetised with keta-
mine (Vetoquinol UK Ltd., Buckingham, UK) and
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Rompun (Bayer Health Care, Kiel, Germany) and the pu-
pils dilated and moisturised as described above. Scotopic
ERG was recorded via mouse corneal ERG electrodes in
response to a single white light flash produced by the
Diagnosys Espion ERG system. For each animal, 8 light in-
tensities ranging from 0.008 to 25 cd s/m2 were applied.
A-wave and B-wave amplitudes were measured using the
Espion analysis software (Diagnosys Technologies, USA).
Spectral domain optical coherence tomography (SD-
OCT) was performed using the Spectralis Heidelberg
OCT system (Heidelberg Engineering, Heidelberg,
Germany), according to manufacturers’ instructions.
Mice were anesthetised and the pupils dilated and
moisturised as described above. OCT images (30° field
of view) were collected from mice at day 28 post-RD.
Fundus images of the retina were acquired using a Mi-
cron IV mouse fundus camera (Phoenix Research Labora-
tories, CA, USA) according to manufacturers’ instructions.
Mice were anesthetised and the pupils were dilated and
moisturised as described above. Fundus photographs were
collected from mice at day 7 and day 28 post-RD.
Ocular histology study
The eyes were collected at different time points following
RD and fixed in 2% paraformaldehyde (Sigma-Aldrich, Dor-
set, UK) for 2 h at room temperature post-enucleation. The
eyes were then washed with PBS and placed in 10%, 20%
and 30% sucrose (Sigma-Aldrich, USA) before embedment
in OCT (optimal cutting temperature) compound and
cryo-sectioned using Leica CM 1900 cryostat (Leica Micro-
systems, Milton Keynes, UK) at 16 μm thickness. H & E
and immunofluorescent staining was performed following
published protocols [18, 19] and antibodies used were listed
in Table 1. A negative control, without the primary anti-
body, was carried out in each staining.
Images were acquired using a Nikon C1 Eclipse
TE200-U (Nikon, UK) or an Olympus IX51 inverted
fluorescent microscope (Olympus, UK) with the same
settings for each antibody. Images were processed using
Fiji software (provided in the public domain, https://ima-
gej.net/Fiji/). Briefly, the number of CD68+ immune
cells, DAPI-labelled nuclei and cone-arrestin+ photo-
receptor cells were counted using a multi-point tool in
Fiji. The number of rod cells was calculated by subtract-
ing the number of cone-arrestin+ cells from the total
DAPI+ cells in the ONL [20]. Synaptophysin+ areas in
the OPL and IPL areas were measured using a free-hand
selection tool in Fiji. GFAP quantification was achieved
by counting GFAP-positive fibres within the INL layer
and post the INL layer of the retina. The data were pre-
sented as mean ± standard error of the mean (SEM),
normalised to 100 μm of retinal length.
Real-time qRT-PCR
Total RNA was extracted using RNeasy Mini Kit (Qia-
gen, Hilden, Germany) and the same amount of RNA
was transcribed into cDNA using SuperScript II Reverse
Transcriptase Kit (ThermoFisher Scientific, Winsford,
UK), following the manufacturer’s instructions. The fol-
lowing validated TaqMan probes were purchased from
Roche (Basel, Switzerland): IL-1β (310471), IL-33
(316824), IL-6 (300699), IL-18 (301115), CCL2 (310467),
vascular endothelial growth factor A (VEGFA, 314944),
glial fibrillary acidic protein (GFAP, 311752), transform-
ing growth factor-β (TGFβ, 317139), tumour necrosis
factor-α (TNFα, 317484), β-actin (307903) and 18S
(307906). SYBR Green gene specific primers were de-
signed using the National Center for Biotechnology In-
formation (NCBI) Primer Blast and synthesised by
Integrated DNA Technologies (Leuven, Belgium). Primer
sequences were listed in Table 2. Quantitative RT-PCR
was performed using a Roche LightCycler 480. Relative
gene expression was calculated using the comparative Ct
method (2−ΔCt) with data normalised to β-actin or 18S.
Cell culture
Primary Müller cell (PMC) cultures were established
from the dissected retina of postnatal day 7 pups [21].
Phenotypes of Müller cell were confirmed (Add-
itional file1: Figure S1). 2.5 × 104 cells were seeded into
12-well plates and cultured in standard cell culture incu-
bator or hypoxic chamber (1% O2) for 24 h. After which,
Table 1 Antibodies used for immunohistochemistry and western blot
Antibody Dilution Company Catalogue number
CD68 1:300 BioRad MCA1957
Cone-arrestin 1:1000 Millipore AB15282
GFAP 1:200 DAKO Z0334
GS 1:2000 Sigma G2781
IL-33 1:50 R & D AF3626
Donkey anti-goat IgG Alexa Fluor 488 1:300 Jackson Immunoresearch 705–545-147
Donkey anti-rabbit IgG Alexa Fluor 488 1:300 Jackson Immunoresearch 711–585-152
Goat anti-rat IgG Alexa Fluor 594 1:300 Invitrogen A-11007
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supernatants were collected and cells were lysed for
RNA extraction.
Bone marrow-derived macrophages (BM-DMs) were
cultured from 8- to 12-week mice using a protocol estab-
lished in the lab previously [22]. Briefly, bone marrow cells
were flushed out from mouse tibias and femurs with
DMEM and then filtered through 100-μm cell strainer
(BD, Oxford, UK). Red blood cells were lysed with lysis
buffer (0.75% NH4Cl, 0.02% Tris–HCl, pH 7.2) on ice for
15min. Bone marrow cells were then cultured in DMEM
supplemented with 10% FBS and 20% L929 conditioned
medium for 7 days, re-plated and stimulated with LPS
(lipopolysaccharides, 50 ng/ml, Sigma-Aldrich, Missouri,
USA) and IFN-γ (interferon-γ, 100 ng/ml, Bio-Techne,
Minnesota, USA) [22]. Supernatants were collected after
24 h, and cells were lysed for RNA extraction.
Cytokine quantification
Supernatants were measured for IL-6, TNFα and CCL2
using Cytometric Bead Array (CBA) Flex sets following the
manufacturer’s guidelines (BD Biosciences, Wokingham,
UK). BD FACSCanto II was used to acquire the samples,
and data were analysed using the FCAP Array™ Software
(BD Biosciences, UK). Nitric oxide (NO) was measured
using the Griess Assay according to the manufacturer’s in-
structions (Promega, Madison, Wisconsin, USA).
Statistical analysis
Data were presented as mean ± SEM. Statistical analysis
was performed using Prism 6 (GraphPad Software, CA,
USA). Normality and equal variance were tested prior to
use unpaired student’s t-test (with or without Welch’s
correction), one-way analysis of variance (ANOVA) or
two-way ANOVA with appropriate post hoc tests. P <
0.05 was considered statistically significant.
Results
Persistent retinal detachment induces photoreceptor
degeneration
In the RD model, the injection of sodium hyaluronate
resulted in detachment of the neuroretina from the
underlying RPE layer (Fig. 1a, arrow). The retina
remained detached during the entire course of this study
(28 days) (Fig. 1b, c). Retinal detachment and photo-
receptor degeneration were confirmed by SD-OCT
(Fig. 1d) and histology (H & E staining) (Fig. 1e, f).
IL-33 and inflammatory gene expression in the detached
retina
Quantitative RT-PCR revealed a significant inflamma-
tory response following RD. In WT RD mice, the expres-
sions of CCL2 (Fig. 2a), complement components C1ra
(Fig. 2b) and C1s (Fig. 2c), cytokines IL-1β (Fig. 2d), IL-
18 (Fig. 2e), IL-33 (Fig. 2g) and GFAP (Fig. 2h) peaked
in the detached retina at day 1. TNFα (Fig. 2f) was not
detectable in normal retinal tissues. It became detectable
post-RD and peaked at day 4 (Fig. 2f). Expression levels
were then gradually reduced and returned to basal levels
at day 28 (Fig. 2a, c–g), except C1ra and GFAP, which
were maintained at significantly higher levels than that
of the controls (Fig. 2b, h). IL-33 was predominantly lo-
cated in the nuclei of Müller cells (Fig. 2i, j) in both de-
tached (Fig. 2i) and normal retina (Fig. 2j). The data
suggest that RD induced an acute retinal inflammation
that lasted for at least 7 days. The inflammatory response
resolved by 28 days after RD.
IL-33 deficiency results in sustained inflammation
following retinal detachment
To understand the role of IL-33 in RD-induced retinal
inflammation, we compared inflammatory gene expres-
sion in the retinas of WT mice and IL-33−/− mice. Under
normal non-diseased conditions, TNFα and IL-6 (data
not shown) were almost undetectable in the retinas of
both strains although IL-33−/− mice had significantly
higher levels of VEGF and C1ra compared with the ret-
ina from WT mice (Fig. 3a). The expression levels of
other genes including CCL2, IL-1β, IL-18, GFAP, TGFβ
and C1s did not significantly differ between both strains
(Fig. 3a). Seven days following RD, the expression of
CCL2, IL-1β, GFAP, TGFβ, C1ra and C1s were in-
creased in both WT and IL-33−/− mice and the upregu-
lated ratios to non-detached control retinas were at the
similar levels (Fig. 3b). The expression levels of VEGF
and IL-18 was not affected by RD in both WT and IL-
33−/− mice (Fig. 3b). TNFα was detectable in both
strains, but IL-6 remained undetectable in all RD retina
(data not shown). At day 28 post-RD, the expression of
inflammatory genes returned to basal level in WT mice
(Fig. 3c), except GFAP and C1ra. However, the expres-
sion levels of CCL2, IL-1β and TGFβ from IL-33−/− RD
mice were still significantly upregulated in comparison
to non-detached control retinas (Fig. 3c). GFAP
Table 2 SYBR Green Primer sequences
Name of Gene Forward primer Reverse primer
C1ra GCCATGCCCAGGTGCCAAGATCAA TGGCTGGCTGCCCTCTGATG
GS TGCCTGCCCAGTGGGAATT TATTGGAAGGGTTCGTCGCC
C1s TGGACAGTGGAGCAACTCCGGT GGTGGGTACTCCACAGGCTGGAA
18S AGGGGAGAGCGGGTAAGAGA GGACAGGACTAGGCGGAACA
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remained upregulated in both WT and IL-33−/− retinas
at day 28 post-RD and was significantly higher in IL-
33−/− mice than those in WT retina (Fig. 3c). The fold
change of GFAP mRNA at day 28 (8.09±1.05) was
higher than that at day 7 (4.64±0.49) (Fig. 3b, c). Im-
munofluorescent staining on ocular sections also dem-
onstrated increased GFAP reactivity in both regions of
detached and non-detached retina in IL-33−/− mice com-
pared to that in WT mice at day 28 post-RD (Fig. 4a–f).
CD68+ immune cells were detected in the subretinal
space/outer retinal layer spaces in the detached areas of
RD mice. Similar numbers of CD68+ cells were detected
at day 4 (Fig. 5a, d, g) and day 7 (Fig. 5b, e, g) in WT
and IL-33−/− mice. However, a significantly higher num-
ber of CD68+ cells were detected in the subretinal/outer
retinal layer spaces in IL-33−/− mice at day 28 compared
to that in WT mice (Fig. 5c, f, g).
Taken together, our data suggest that deletion of IL-33
resulted in persistent retinal gliosis and subretinal in-
flammation following retinal detachment.
IL-33 deficiency results in more severe neuron
degeneration following retinal detachment
To understand the impact of persistent gliosis and sub-
retinal inflammation to photoreceptor degeneration in
IL-33−/− RD mice, visual function was examined by ERG
Fig. 1 Retinal detachment (RD) and photoreceptor degeneration followed the injection of sodium hyaluronate. Two microliters of sodium
hyaluronate was injected into the subretinal space to detach the neuroretina from RPE. a Representative photograph showing retinal detachment
immediately following the injection of sodium hyaluronate. Arrow, detached retina. b, c Fundus image showing retinal damage at day 7 (b) and
day 28 (c) post-RD. Arrow, detached area; arrowhead, non-detached area. d SD-OCT showing detached (arrow) and non-detached area
(arrowhead) in the same eye at day 28 post-RD. Photoreceptor layer is thinner in the detached area (arrow). e, f Histology showing the intact
photoreceptor cells and segments in normal ocular section (e) and detached retina (f, arrow, photoreceptor and segment loss) at day 28 post-RD.
Scale bar, 100 μm
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at day 28 post-RD. There was no difference in the ampli-
tude of A- and B-waves between normal IL-33−/− and
WT mice (Fig. 6a, b). Retinal detachment resulted in sig-
nificant reductions in the amplitudes of both A- and B-
waves in both strains; however, the reduction in A-wave
was more severe in IL-33−/− RD mice compared to that
in WT RD mice (Fig. 6a, b).
Reduction of A-wave suggested photoreceptor cells de-
generation. The number of photoreceptor nuclear layer
(Fig. 6c), the number of cone arrestin+ cells (Fig. 6d),
Fig. 2 RD results in an acute inflammatory response in WT retina. At different days following RD, the retinas were collected and processed for RT-
PCR analysis of inflammatory genes in WT mice (a–f). The mRNA expression of CCL2 (a), C1ra (b), C1s (c), IL-1β (d) and IL-18 (e) at days 1, 4, 7,
and 28 post-RD. f The expression level of TNFα peaked at day 4 and remained at the peak at day 7 and returned back to the basal level at day
28 post-RD. g The expression level of IL-33 peaked at day 1, then decreased towards the basal level at day 28 post-RD. h The expression level of
GFAP peaked at day 1 and reduced gradually. At day 28 post-RD, the expression level of GFAP was maintained at a higher level than control.
Data presented as mean ± SEM, n = 6 per group, one-way ANOVA followed by Dunnett’s multiple comparisons test, *P < 0.05, **P < 0.01, ***P <
0.001. i, j Representative images of retinal sections stained for glutamine synthetase (red, marker for Müller cells), IL-33 (green) and DAPI (blue) in i
detached retina (day 28 post-RD) and j normal retina. IL-33 was localised in the nuclei of Müller cells, and no significant IL-33 signal (green) could
be observed out of Müller cells in detached retina. Scale bar, 50 μm
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Fig. 3 Deletion of IL-33 results in sustained retinal inflammation and gliosis post-RD. a Expression levels in normal WT and IL-33−/− mice. IL-33−/−
retina expressed significantly higher levels of VEGF and C1ra. CCL2, IL-1β, IL-18, GFAP, TGFβ and C1s were at similar levels. b Expression levels at
day 7 post-RD. Gene expression levels from day 7 were compared with control retina from the same strain. Upregulated genes to that of RD
control were identified in boxes. Expression levels were increased at the similar level in both strains. c Expression levels of retina at day 28 post-
RD. Gene expression levels from day 28 were compared with that of control retina from the same strain. Upregulated genes to that of RD control
were identified in boxes. Most mRNA levels returned to basal levels at day 28; however, CCL2, IL1β, GFAP and TGFβ in IL-33−/− retina were higher
than in WT. a–c n = 6, Student’s t test, *P < 0.05, **P < 0.01, ***P < 0.001
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and the number of rod photoreceptor cells (Fig. 6d) were
quantified from images stained with cone arrestin and
DAPI (Fig. 6e). The number of photoreceptor nuclear
layers and the number of cone and rod photoreceptor
cells were similar in control WT and IL-33−/− mice
(Fig. 6c–e). There is no significant reduction in nuclear
layers and rod photoreceptor cells at the non-detached
area of the detached eyes compared to the control eyes
in both WT and IL-33−/− mice (Fig. 6c–e). The number
of cone-arrestin+ cell at the non-detached area of the de-
tached eyes remained unchanged compared to that of
the non-detached control eyes in WT mice but was sig-
nificantly reduced in IL-33−/− mice (Fig. 6c–e). Photo-
receptor nuclear layers in the detached areas were
significantly thinner than in normal eyes and non-
detached area in the detached eye in both WT and IL-
33−/− mice; however, there was no difference between
WT and IL-33−/− mice. The number of rod photorecep-
tor cells and cone-arrestin+ cells in the detached area
was significantly reduced in both WT and IL-33−/− mice,
and the reduction in cone-arrestin+ cells was more
severe in IL-33−/− mice compared to that in WT mice
(Fig. 6d–e).
Synaptic vesicles were identified using synaptophy-
sin immunostaining. Areas of synaptophysin in the
outer plexiform layer (OPL) and inner plexiform
layer (IPL) were quantified as previously described
[20]. The synaptophysin+ areas were at the compar-
able levels in both the OPL and IPL in non-detached
control WT and IL-33−/− mice. RD resulted in sig-
nificantly reduced synaptophysin-positive regions in
the OPL and IPL in both detached area and non-
detached area at day 28 post-RD in both IL-33−/−
and WT mice (Fig. 6f, g). In the IPL, the reduction
levels in the detached area or non-detached area
were similar between the two strains of mice,
whereas the reduction was more severe in the OPL
of detached areas in IL-33−/− mice compared to that
in WT mice (Fig. 6f, g). This data shows that RD-
induced photoreceptor and synaptophysin loss was
more severe in IL-33−/− mice compared to that in
WT mice.
Fig. 4 GFAP expression in the retina from WT and IL-33−/− mice day 28 post-RD. The number of GFAP+ fibres retained within the GCL and INL
layers (a) and across the whole retina (b) in the detached and non-detached regions from the same retina. Data presented as mean ± SEM. n = 5
mice, 3–6 sections per retina, two-way ANOVA followed by Bonferroni’s multiple comparisons test, *P < 0.05. c–f Representative images of day 28
post-RD showing GFAP (red) and DAPI (blue) in c WT non-detached, d WT detached, e IL-33−/− non-detached and f IL-33−/− detached regions.
GCL ganglion cell layer, INL inner nuclear layer, ONL outer nuclear layer, ND non-detached region, DE detached region. Scale bar, 50 μm
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IL-33 deficiency does not induce inflammatory phenotype
in primary Müller cells
Since IL-33 is predominately expressed by Müller cells
in the retina, we then investigated inflammatory cytokine
expression in PMCs from WT and IL-33−/− mice. Under
normal culture conditions, PMCs from IL-33−/− mice
expressed significantly lower levels of CCL2 and IL-6
compared to the cells from WT mice (Fig. 7a). The ex-
pression levels of IL-18, VEGF, TGFβ, GFAP and glu-
tamine synthetase (GS) were comparable between WT
and IL-33−/− cells (Fig. 7a). The mRNA expression of
TNFα and IL-1β were undetectable in both PMCs (data
not shown).
Under hypoxic conditions (1% O2), the expression of
VEGF was significantly increased in PMCs isolated from
WT and IL-33−/− mice (Fig. 7b), whereas the expression
of CCL2, IL-6 and IL-18 was significantly decreased in
both PMCs compared to that in normal control culture
conditions (Fig. 7b). Other genes, including TGFβ,
GFAP and GS were not altered by hypoxia in both types
of cells (Fig. 7b). Cytokines released into the culture
media were selectively measured using CBA. Hypoxia
significantly reduced the production of CCL2 in both
WT and IL-33−/− Müller cells (Fig. 7c), and the reduc-
tion were more pronounced in IL-33−/− PMCs (Fig. 7c).
IL-6 production was lower in IL-33−/− PMC under con-
trol conditions (Fig. 7d), hypoxia significantly reduced
the production of IL-6 in both cell types (Fig. 7d) and
the reduction was more significant in IL-33−/− PMCs
(Fig. 7d). Our data suggest that IL-33 deletion
suppresses a pro-inflammatory phenotype in Müller cells
and reduces CCL2 and IL-6 production under control
and hypoxic conditions.
Macrophages from IL-33−/− mice express higher levels of
inflammatory cytokines
BM-DMs showed similar levels of pro-inflammatory
gene expressions before the treatment of LPS + IFNγ
(Fig. 8a). Following LPS + INFγ stimulation, BM-DMs
from IL-33−/− mice showed higher levels of pro-
inflammatory gene expressions, including CCL2, IL-1β,
TNFα and inducible nitric oxide synthase (iNOS), than
those from WT BM-DMs (Fig. 8b), the expression levels
of IL-6 were similar between WT and IL-33−/− cells
(Fig. 8b). TNFα and nitric oxide (NO) in the superna-
tants from IL-33−/− macrophages were also higher than
those from WT macrophages (Fig. 8c and d).
Discussion
In this study, we show that IL-33 is upregulated in
Müller cells following experimental RD and this was ac-
companied by a sustained gliosis and subretinal inflam-
mation. We also showed that IL-33−/− mice developed
more severe retinal degeneration following retinal
detachment.
Early study on adult cat has shown that RD-induced
apoptotic photoreceptor death (TUNEL+ cells) occurs at
the acute (i.e., day 1 and day 3 after RD) but not the
chronic (day 28 after RD) stage of the disease [23]. This
observation was further confirmed in mouse and rat
Fig. 5 Deletion of IL-33 results in increased immune cell infiltration following detachment. a–f Representative images of WT and IL-33−/− retinal
sections stained for CD68 (red) and DAPI (blue) in a WT day 4, b WT day 7, c WT day 28, d IL-33−/− day 4, e IL-33−/− day 7 and f IL-33−/− day 28
post-RD. g The number of CD68+ cells in the subretinal spaces of WT and IL-33−/− eyes at day 4, day 7 and day 28 post-RD. Data were presented
as mean ± SEM. n = 5 mice, 3–6 sections per retina, Student’s t test were used to compare the cell number between two groups at the same
time point. ***P < 0.001. Scale bar, 100 μm
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Fig. 6 Deletion of IL-33 results in more severe neuron degeneration following RD. a–b Scotopic ERGs of WT and IL-33−/− at day 28 post-RD. Line
graph of A-wave amplitudes (a) and B-wave amplitudes (b) at flash intensities ranging from 0.008 to 25 cd s/m2 were quantified. Data were
presented as mean ± SEM, n = 5–12 eyes per experimental condition; arrow, day 28 post-RD. Student’s t test was used to compare the amplitudes
between WT and IL-33-/- at the same flash intensity. *P < 0.05. c–e Photoreceptor degeneration in WT and IL-33−/− retina at day 28 post-RD was
investigated using immunohistochemistry of cone-arrestin. c The number of nuclear layer of the ONL in normal retina, non-detached area and
detached area of RD retina. d The number of rod cells, cone-arrestin+ cells in normal retina, non-detached area and detached area of RD retina. e
Representative images of WT and IL-33−/− retinal sections stained for cone-arrestin (red) and DAPI (blue). f–g Synaptic integrity in WT and IL-33−/−
retina at day 28 post-RD was investigated using immunohistochemistry of synaptophysin. f The area of synaptophysin in OPL and IPL in normal
retina and detached and non-detached regions of RD retina. g Representative images of WT and IL-33−/− retinal sections stained for
synaptophysin (green) and DAPI (blue). GCL ganglion cell layer, INL inner nuclear layer, ONL outer nuclear layer, OPL outer plexiform layer, IPL
inner plexiform layer, CON control retina, ND non-detached region of retina having RD, DE detached region of retina having RD. Data presented
as mean ± SEM. n = 5 mice, 3–6 sections per retina. Student’s t test was used to compare the means between WT and IL-33-/- at the same
condition. *P < 0.05, **P < 0.01. Scale bar, 50 μm
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models of RD by Hisatomi and colleagues [24], where
the authors detected photoreceptor death as early as 12
h after RD, which peaked at day 3 and then gradually di-
minished [24]. Hisatomi et al. also found that the ONL
thickness continued to decrease over 28 days after RD
[24], suggesting that an apoptotic-independent photo-
receptor degeneration exists at the late stages of RD.
Multiple pathways are known to be involved in the RD-
induced photoreceptor death, including the caspase
pathway (through apoptosis or inflammasome activa-
tion), autophagy, mitochondrial dysfunction, inflamma-
tion and gliosis [25]. GFAP is a marker of gliosis and is
“non-specifically” increased in reactive glia. In the nor-
mal retina, GFAP is expressed in astrocytes and the end-
feet of Müller cells at the optic nerve/ganglion cell layer
(GCL). The expression of GFAP in Müller cell is
upregulated upon activation and can be detected across
the entire cell body. Previous studies have shown that
deletion of GFAP or vimentin can prevent RD-induced
gliosis and rescue photoreceptor degeneration, which
highlights the critical role of Müller cells play in modu-
lating the acute response to retinal damage [26]. IL-33 is
expressed predominately in Müller cells in the retina,
and we found that its expression was further increased
in the acute phase of RD. In the current study, RD re-
sulted in more severe gliosis in IL-33−/− mice, accom-
panied by a more severe photoreceptor degeneration as
evidenced by a significantly lower number of cone-
arrestin+ cells, reduced synaptic vesicles in OPL and re-
duced A-wave response in ERG. The physiological func-
tion of gliosis is not fully understood although it has
been linked to both protective and detrimental roles [1].
Fig. 7 Primary Müller cells from WT and IL-33−/− mice present similar inflammatory response. a mRNA levels of CCL2, IL-6, IL-18, VEGF, TGFβ,
GFAP, GS in WT and IL-33−/− PMC cultured in standard incubators. Expression levels of CCL2 and IL-6 was lower in IL-33−/− PMC, whereas other
genes were at similar levels. b mRNA level of PMCs cultured in 1% hypoxia for 24 h. Expression level was compared to PMC from the same strain.
Fold changes above the dotted line suggested increased response in hypoxia (VEGF); fold changes below the dotted line suggested decreased
response in hypoxia (CCL2, IL-6 and IL-18). c, d Cytokine concentration in culture supernatants were measured by CBA. Hypoxia reduced the
secretion of CCL2 and IL-6 in both WT and IL-33−/− PMCs. Data presented as mean ± SEM, n = 3. a, b Student’s t test. c, d Two-way ANOVA
followed by Tukey’s multiple comparisons. n = 6, *P < 0.05, **P < 0.01, ***P < 0.001. CBA cytometric beads array
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Fig. 8 (See legend on next page.)
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In our study, primary Müller cell cultures from WT and
IL-33−/− mice express comparable levels of GFAP under
control and hypoxic conditions; GFAP gliosis in WT
and IL-33−/− mice was comparable at the acute phase of
RD (within 7 days). But the IL-33−/− mice has more se-
vere gliosis at the chronic stages of RD (i.e., at day 28),
suggesting that IL-33 may be critically involved in RD-
induced inflammatory response at the late stages of the
disease.
Although IL-33 is considered as an alarmin when re-
leased from damaged cells, it also has important immune
regulatory roles. In the central nervous system (CNS),
the glia-derived IL-33 is known to orchestrate tissue im-
mune response and promote recovery after injury [27].
IL-33 is expressed by oligodendrocytes and is released
upon CNS injury. The extracellular IL-33 then binds to
the receptor ST2 on microglia and astrocytes, leading to
chemokine (e.g., CCL2) production and subsequent re-
cruitment of circulating immune cells [27]. Mice lacking
IL-33 have impaired recovery after CNS injury due to
less myeloid cell, in particular, reparative M2 macro-
phage infiltration at the injury site [27]. IL-33 can also
promote resolving of inflammation and recovery from
acute colitis by inducing miR-320 to stimulate epithelial
restitution and repair [28]. Interestingly, the IL-33/ST2
pathway may also participate in a pro-inflammatory re-
sponse and contribute to CNS damage. Cao and col-
leagues reported that LPS-induced neuroinflammation is
reduced in IL-33−/− mice and microglia from IL-33−/−
mice produce significantly lower levels of inflammatory
mediators such as TNF-α, IL-6, IL-1β and CCL2 after
LPS treatment [29]. The opposite roles of IL-33 in CNS
injury and LPS-induced neuroinflammation suggests that
IL-33 may function differently under different disease
conditions.
We have shown previously that IL-33 can suppress
retinal inflammation in a mouse model of autoimmune
uveoretinitis through induction of type 2 cytokines and
M2 macrophages [12]. Theodoropoulou et al. reported
that IL-33 has anti-angiogenic roles in the mouse model
of laser-induced choroidal neovascularisation through
the reduction of choroidal endothelial and fibroblast ac-
tivation and migration [13]. However, Xi and colleagues
have found that IL-33+ Müller cells can promote retinal
inflammation in retinal injury and during age-related
macular degeneration [14]. The authors found that IL-
33 was released by Müller cells after light exposure,
which then induced CCL2, IL-6 and IL-1β expression
through autocrine activation of Müller cells [14] and
promoted immune cell infiltration and retinal degener-
ation [14]. In this study, we found that in vitro cultured
Müller cells from IL-33−/− mice produced lower levels of
CCL2 and IL-6 compared to cells from WT mice,
whereas the expression of TNFα, IL-1β, IL-10 and VEGF
did not differ between the two types of cells. The results
suggest that IL-33 may positively regulate CCL2 and IL-
6 expression in Müller cells.
Seven days after retinal detachment, retinal inflamma-
tory gene expression, CD68+ immune cell infiltration
and GFAP expression were comparable between WT
and IL-33−/− mice, suggesting that IL-33 depletion did
not affect RD-mediated defence response at the acute
stages of retinal injury. RD-mediated retinal inflamma-
tory response resolved almost completely in WT mice
but persisted in IL-33−/− mice at day 28. Our results sug-
gest that IL-33 may play an important role in the reso-
lution of inflammation in this model, which is in line
with a previous study in the CNS [27].
Exactly how IL-33 participates in the resolution of ret-
inal inflammation in our model system remains un-
known. After the retina is detached from the RPE,
damaged neurons release a large amount of damage-
associated molecular patterns (DAMPs) that induce
acute inflammation characterised by pro-inflammatory
cytokine expression and macrophage (M1) infiltration.
The resolution of inflammation may be initiated when
the DAMPs are removed. Anti-inflammatory, tissue re-
pair M2 macrophages are known to play an important
role in resolving inflammation. Although macrophages
are highly plastic, M1 macrophages are unable to re-
differentiate into M2 macrophages due to irreversible
damage to mitochondrial electron transport chain by
nitric oxide during inflammatory activation [30].
Therefore, the anti-inflammatory macrophages must
be recruited to the detached retina at the late stage
of disease. The persistent inflammation in the IL-
33−/− RD retina may be related to the delayed clear-
ance of inflammatory M1 macrophages or the lack of
recruitment of or inability to induce anti-
inflammatory M2 macrophages.
(See figure on previous page.)
Fig. 8 Bone marrow-derived macrophages from IL-33−/− mice are more pro-inflammatory after classic stimulation (LPS/IFNγ). a, b mRNA
expression of inflammatory genes including iNOS, TNFα, IL1-β, CCL2 and IL-6 before (a: M0) or after (b: M1) LPS + INFγ treated BM-DMs cultured
from WT and IL-33−/− mice. Y-axis showing the fold changes of mRNA expression level compared to non-stimulated BM-DM. Dot line levels fold
change at 1. RNA levels were upregulated after stimulation for each cell type. The increased levels of iNOS, TNFα, IL-18 and CCL2 of IL-33−/−
BMDMs were significantly higher than those of WT BM-DMs. c Secretion of TNFα was higher in IL-33−/− BM-DM than in WT. d The concentration
of NO released into the culture medium from IL-33−/− BM-DM was higher than those in WT BMDM. NO nitric oxide. Data presented as mean ±
SEM, n = 3, Student’s t test, *P < 0.05, **P < 0.01, ***P < 0.001
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Conclusion
In this study, we have demonstrated that RD resulted in
persistent gliosis, sustained subretinal inflammation, im-
mune cell infiltration and severe photoreceptor degener-
ation in IL-33−/− mice. IL-33 may positively regulate
CCL2 and IL-6 expression in Müller cells, but negatively
regulate inflammatory macrophage activation. Based on
the present data, the IL-33 pathway warrants further
scrutiny as a possible therapeutic avenue in inflamma-
tory and degenerative retinal diseases.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
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Additionalfile1: Figure S1. Immunofluorescent staining was conducted
to confirm the phenotypes of primary Müller cells from WT and IL-33−/−
retinas. IL-33 (green) was positive in WT PMC, but not IL-33−/− PMC. Both WT
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(red), GFAP (red), SMA (smooth muscle actin alpha, red), Kir4.1 (green), and
Aquaporin 4 (red). DAPI is in blue. Scale bar: 25 μm. (TIF 254 kb)
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